Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CMPS
CMPS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CMPS News
COMPASS Pathways Reports Earnings and Financing Details
6d ago
seekingalpha
COMP360 Achieves Breakthrough in Treatment-Resistant Depression
6d ago
Newsfilter
COMPASS PATHWAYS REPORTS Q4 OPERATING EXPENSES OF USD 45.952 MILLION
6d ago
moomoo
COMPASS PATHWAYS RELEASES FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS FOR FOURTH QUARTER AND FULL YEAR 2025
6d ago
moomoo
Compass Pathways to Attend Stifel 2026 Virtual CNS Forum
Mar 12 2026
Newsfilter
Helus Pharma Advances New Drug for Anxiety Treatment
Mar 09 2026
Newsfilter
Helus Pharma Advances Mental Health Treatments with Promising Phase 2 Results
Mar 09 2026
PRnewswire
Helus Pharma's Psychedelic Drug Achieves Phase 3 Success
Feb 26 2026
PRnewswire
Helus Pharma Achieves Breakthrough in Depression Treatment
Feb 26 2026
Newsfilter
Compass Pathways Exercises Warrants Raising $200 Million
Feb 26 2026
seekingalpha
Compass Pathways Exercises 35 Million Warrants for $200 Million
Feb 26 2026
Newsfilter
Mental Health Treatment Market Set for Accelerated Growth
Feb 24 2026
PRnewswire
Mental Health Drug Market Set for Accelerated Growth
Feb 24 2026
Newsfilter
Compass Pathways to Attend TD Cowen Healthcare Conference
Feb 24 2026
Businesswire
Weekly Roundup: Cannabis and Psychedelic Sector Developments
Feb 23 2026
Yahoo Finance
"Compass Pathways Secures Trial Victory and Rapid Funding with Magic Mushrooms and Cash"
Feb 20 2026
Marketbeat
Show More News
